Australia's largest stock trading and investment forum Australia's #1 stock forum

ALT

0.00%

0.1¢ analytica limited

Ann: Positive clinical trial results for Pericoach, page-10

First 10 Last

Share
Profile

Follow
bevter

25,780 Posts.

1249

23/02/17

09:12

Post #: 22832417
Share

Originally posted by PeasantOne ↑

Ffs, we waited all this time for trial results on only 47 participants!
And I was told it was a very large trial. Mistrust has returned.
More issues on their language for me. 'Superior' and 'significant improvement' are descriptive words open to interpretation. FACTS are in the actual scores which they've chosen to omit.
So it's a safe assumption those scores are not particularly good. The fact that again Quality of Life & Sexual Satisfaction are noted ahead of UI improvements, a change from past language, to my mind supports this view.
Using pad weight as a guide there is no difference between the Control group and PeriCoach users. Yet somehow (they don't reveal how) they've concluded Peri users are twice more likely to achieve a 30% or better reduction. Can someone explain that for dummies like me please.
They are not saying any participants actually achieved that 30% mark; but in the same paragraph state PF measurements by Oxford Scale are not linear as many women stay at mid level for long time periods. I'm a peasant not a scientist and unless one of you can interpret for me wtf that means and it's relevance I'll conclude they're trying to baffle us with bullshit.
I see nothing to support the idea PeriCoach will be mandatory before last resort surgery.
No timeframe given for essential V3 consumer studies.
We're not going anywhere soon.

Expand

It's up so maybe you should sell?

ALT Price at posting: 0.8¢ Sentiment: Hold Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

ESR

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

The market's shrugged at China's stimulus measures all year. Why is this one different?

STK

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

The winners & losers on market if negative gearing were gone

DEG

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

KAL

KalGold rolls out detailed aeromagnetic survey across Pinjin project

NAM

ACCC seeks Olam divestments before it can buy Namoi Cotton

There are more pages in this discussion • 23 more messages in this thread...

First 10 Last

Add ALT (ASX) to my watchlist

Ann: Positive clinical trial results for Pericoach, page-10

Top Stories

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

The market's shrugged at China's stimulus measures all year. Why is this one different?

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

The winners & losers on market if negative gearing were gone

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

KalGold rolls out detailed aeromagnetic survey across Pinjin project

ACCC seeks Olam divestments before it can buy Namoi Cotton

Featured News